跳至主要内容
临床试验/NCT02898961
NCT02898961已完成4 期

Impact of 30 mg/kg Amikacin and 8 mg/kg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis

Centre Hospitalier Universitaire de Nīmes1 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2014年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
63
试验地点
1
主要终点
Presence/absence of target peak serum concentration of aminosides

研究概览

简要总结

Low first-dose peak serum concentrations of amikacin and gentamicin are commonly reported in ICU patients. The present study aimed to assess whether 30 mg/kg amikacin or 8 mg/kg gentamicin achieved target concentrations in ICU patients with severe sepsis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •ICU patient with severe sepsis
  • •Treated with aminoglycosides

排除标准

  • •Renal replacement therapy
  • •Allergy to aminoglycosides
  • •Confirmed and/or suspected to have myasthenia
  • •ICU-acquired neuromuscular disorder
  • •Under guardianship
  • •Prisoners
  • •The patient has already participated in the present protocol

研究组 & 干预措施

The study population

Experimental

ICU patients with severe sepsis treated with aminoglycosides were recruited.

Intervention: 30 mg/kg amikacin or 8 mg/kg gentamicin

干预措施: 30 mg/kg amikacin or 8 mg/kg gentamicin (Drug)

结局指标

主要结局

Presence/absence of target peak serum concentration of aminosides

时间窗: 30 minutes after the end of the infusion.

Achievement of targeted peak serum concentration?

次要结局

未报告次要终点

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验